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Astrocytes release glutamate upon activation of
various GPCRs to exert important roles in synaptic
functions. However, the molecular mechanism of
release has been controversial. Here, we report two
kinetically distinct modes of nonvesicular, channel-
mediated glutamate release. The fast mode requires
activation of Gai, dissociation of Gbg, and subsequent
opening of glutamate-permeable, two-pore domain
potassium channel TREK-1 through direct interac-
tion between Gbg and N terminus of TREK-1. The
slow mode is Ca2+ dependent and requires Gaq
activation and opening of glutamate-permeable,
Ca2+-activated anion channel Best1. Ultrastructural
analyses demonstrate that TREK-1 is preferentially
localized at cell body and processes, whereas
Best1 is mostly found in microdomains of astrocytes
near synapses. Diffusion modeling predicts that the
fast mode can target neuronal mGluR with peak
glutamate concentration of 100 mM, whereas slow
mode targets neuronal NMDA receptors at around
1 mM. Our results reveal two distinct sources of
astrocytic glutamate that can differentially influence
neighboring neurons.
INTRODUCTION
Glutamate is the principal excitatory neurotransmitter in the
brain. In the central nervous system, both neurons and astro-cytes are known to release glutamate; the neuronal glutamate
mediates fast synaptic transmission (Traynelis et al., 2010),
whereas the astrocytic glutamate appears to modulate synaptic
transmission (Haydon andCarmignoto, 2006). Although it is clear
that neurons release glutamate via Ca2+-dependent exocytosis,
the mechanism of astrocytic glutamate release has been heavily
debated, and many controversial issues have been raised (Ham-
ilton and Attwell, 2010; Nedergaard et al., 2002). The field seems
to be divided into three conflicting views: (1) astrocytes release
glutamate by vesicular exocytosis, just like neurons (Bezzi
et al., 2004; Jourdain et al., 2007); (2) Ca2+-dependent astrocytic
glutamate does not do anything important (Agulhon et al., 2010);
or (3) glutamate is released from astrocytes by transporters or
channels (Cavelier and Attwell, 2005; Hamilton and Attwell,
2010; Li et al., 2012; Takano et al., 2005; Ye et al., 2003). Such
controversies most likely stem from the inconsistencies in
procedures used to increase intracellular Ca2+, such as UV pho-
tostimulation (Parpura et al., 1994), mechanical stimulation
(Araque et al., 1998, 2000; Montana et al., 2004), electrical stim-
ulation (Jourdain et al., 2007; Kang et al., 1998), uncaging of
caged Ca2+ or IP3 (Araque et al., 1998; Fiacco and McCarthy,
2004; Parpura and Haydon, 2000), and G-protein-coupled
receptor (GPCR) agonists (Lee et al., 2007; Takano et al.,
2005). More importantly, there is no sensitive method to detect
glutamate release from individual astrocytes. Conventional tech-
niques include fluorescence imaging of glutamate dehydroge-
nase activity through NAD+ to NADH conversion (Innocenti
et al., 2000), detection of preloaded radioactive glutamate
release (Farinelli and Nicklas, 1992), and high-performance
liquid chromatography (HPLC) (Obrenovitch and Zilkha, 2001;
Takano et al., 2005). However, these methods lack the desired
submillisecond temporal resolution. In contrast, it has beenCell 151, 25–40, September 28, 2012 ª2012 Elsevier Inc. 25
Figure 1. Signaling Pathway of the Receptor-Mediated Glutamate Release from a Single Astrocyte
(A) Schematic illustration for sniffer-patch technique. Left pipette (yellow), pressure application of TFLLR. Right pipette, recording pipette for HEK293T cell
expressing GluR1-L497Y (green, sensor cell). Red cloud, gliotransmitters released from cultured astrocyte (blue) upon TFLLR application.
(B) Images for sniffer patch. DIC image (upper left), two cells with two glass pipettes. GFP image (upper right), sensor cell expressing GluR1-L497Y and EGFP.
Pseudocolor images, Fura-2 loaded astrocyte (source cell) and sensor cells before TFLLR (lower left) and after TFLLR (lower right). Yellow arrow, increased
Ca2+ in astrocyte.
(C) Representative traces recorded from sniffer-patch technique. Blue trace, Ca2+ transient recorded from astrocyte. Green trace, whole-cell current recorded
from sensor cell (Vh = 70mV) upon TFLLR pressure application. Diamond, TFLLR application (10 psi, 100 ms, 500 mM).
(D) Full activation current recorded by bath application of 1 mM glutamate in sensor cell to measure total surface expression of GluR1-L497Y.
(E) Lower current trace, almost complete inhibition of fast mode after treating with 1 mg/ml PTX (12–18 hr).
(F) Lower current trace, a rescue of fast mode in PTX-treated astrocyte overexpressing GiCG.
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relatively easy to understand the exocytosis-mediated release
of glutamate from presynaptic vesicles because of the avail-
ability of high-sensitivity sensors for synaptic glutamate release,
namely the postsynaptic AMPA and NMDA receptors (Clements
et al., 1992).
In our previous study, we developed the ‘‘sniffer-patch’’ tech-
nique, a highly sensitive method for detecting astrocytic gluta-
mate release that is based on a biosensor consisting of
HEK293T cells that transiently express a nondesensitizing
mutant form of the AMPA receptor subunit, GluR1-L497Y (Lee
et al., 2007). This receptor has a high affinity for glutamate
(median effective concentration [EC50] = 6.1 mM), allowing
detection of submicromolar glutamate levels, a fast activation
rate (submillisecond) for detection of rapid release, and a fast
deactivation rate (0.7–1.2 ms) for better kinetic separation of
different components of glutamate release (Traynelis et al.,
2010). To stimulate individual astrocytes with more physiological
stimuli, we activated endogenous GPCRs by pressure-applied
TFLLR (Hollenberg et al., 1997), a selective peptide agonist of
the protease-activated receptor 1 (PAR1). PAR1 is a GPCR
that is activated via serine proteases such as thrombin and
plasmin by proteolytic cleavage of the N terminus of the
receptor, revealing a tethered ligand with a peptide sequence
of SFLLRN, which acts as an agonist (Macfarlane et al., 2001).
TFLLR mimics the tethered ligand and has been shown to be
more selective to PAR1 over PAR2 than the native peptide
sequence, SFLLRN (Hollenberg et al., 1997). PAR1 is functionally
expressed in most of CA1 hippocampal astrocytes, but not in
CA1 pyramidal neurons (Junge et al., 2004), and is linked to
Gi/o, Gq/11, and G12 proteins (Sorensen et al., 2003).
In the present study, we utilized the sniffer patch to dissect the
detailed mechanism of GPCR-induced glutamate release in
astrocytes. We found that astrocytes release glutamate not by
conventional vesicular exocytosis but by the opening of gluta-
mate-permeable ion channels. Furthermore, we found that the
drugs or agents that are assumed to inhibit exocytosis and are
used to support the vesicular theory of astrocytic glutamate
release strongly reduced the surface expression of multiple ion
channels, including those that mediate glutamate release.
RESULTS
Characterization of Fast and Slow Modes of Glutamate
Release
The general scheme of sniffer patch is illustrated in Figure 1A. On
the day of experiment, sensor cells were mixed with astrocytes
and allowed to randomly settle on top of individual astrocytes(G) Summary bar graph for percentage of full activation in each indicated con
indicates n for each condition.
(H) Lower current trace, inhibition of fast mode in astrocyte overexpressing C ter
(I) Summary bar graph for C terminus of phosducin and b-ARK (*p = 0.015; **p =
(J) Representative trace for Baclofen (inverted triangle, 100 ms, 300 mM).
(K) Summary graph for percentage of full activation of Gi-coupled GPCR agonist
(L) Lower trace, inhibition of slow mode in astrocyte overexpressing RGS-2.
(M) Summary graph for RGS-2-expressing astrocytes (*p = 0.032).
(N) Representative traces for before and after 20 mM BAPTA-AM (30 min) treatm
(O) Summary graph for BAPTA-AM treatment (*p = 0.031).
All values are mean ±SEM. See also Figures S1 and S2.(Figure S1A available online). The sensor cell was then whole-cell
patch clamped to monitor released glutamate from its nearby
astrocyte. TFLLR was applied while simultaneously monitoring
Fura-2 intensity ratio for astrocytic Ca2+ signal (Figures 1B
and 1C) (Lee et al., 2007).
Upon TFLLR application, glutamate release was detected as
an inward current in the sensor cell mediated by GluR1-L497Y.
Glutamate release consisted of both fast (latency: 120.0 ±
13.3 ms, n = 33) and slow (time at the peak: 20.2 ± 2.5 s,
n = 33) modes (Figure 1C). TFLLR application never induced
a current in the sensor cell in the absence of an astrocyte (Figures
S1C and S1G). In the presence of astrocyte buffer without TFLLR
or RLLFT, a reverse peptide of TFLLR never caused a sensor
current (Figures S1D andS1E). However, SFLLR caused a robust
sensor current (Figure S1F), just like TFLLR. Bath application of
1 mM glutamate was used to fully activate the GluR1-L497Y
channels expressed in the sensor cell (Figure 1D) and to thereby
estimate the percent of full activation of GluR1-L497Y activated
by astrocytic glutamate release. This percentage can be easily
converted to the concentration of glutamate, based on the
concentration-response relationship of GluR1-L497Y (Lee
et al., 2007). Each response could be categorized into three
groups: fast only, slow only, and both modes (Figures S1H–
S1J). Most of astrocytes fell into the ‘‘both’’ category (69.3%),
though the existence of fast-only (18.1%) and slow-only
(12.6%) responses raised the possibility that each component
is mediated by a distinct mechanism. The average fraction of
receptor activation at the peak of response was greater for the
fast mode than for the slow (Figure S1K). However, the total
charge was much greater for the slow mode than for the fast
(Figure S1L). These two modes and the full-activation current
were almost completely blocked by the AMPA receptor blocker
CNQX (Figures S1H–S1J, right panels, S1M, and S1B), indi-
cating that glutamate is responsible for both the fast and slow
modes. The TFLLR-induced glutamate release was readily
repeatable with 10 min intervals (Figure S1N). The fast mode
preceded the onset of TFLLR-induced Ca2+ increase (Figures
1C and S1O–S1Q), implying the involvement of a Ca2+-indepen-
dent release mechanism. In contrast, the slow mode occurred in
association with the rise of astrocytic Ca2+ (Figure S1R), implying
a Ca2+-dependent mechanism. The response to the fast mode of
astrocytic glutamate release was as fast as the response to
exocytosis-mediated neuronal release, suggesting a very rapid
mechanism (Figures S1S–S1X).
To examine the signaling pathways mediating the fast and
slow modes of glutamate release, we utilized various molecular
and pharmacological tools. Because the PAR1 receptor is linkeddition (**1, p = 0.005; **2, p = 0.001; unpaired t test). Number on each bar
minus of phosducin (Phos-ct).
0.002).
s. CCPA (100 ms, 1 mM) and ACEA (100 ms, 300 mM) induce fast mode.
ent in the same astrocyte/sensor cell.
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to both Gi/o and Gq/12, we selectively inhibited the Gi pathway by
preincubating astrocytes with pertussis toxin (PTX), which is
known to inhibit the action of Gi subunit by ADP-ribosylation
(West et al., 1985). We found that PTX selectively and almost
completely blocked the fast, but not the slow,mode of glutamate
release (Figures 1E and 1G) without affecting astrocytic Ca2+
responses (Figures S2A and S2B). This selective inhibition by
PTXwas significantly rescued by overexpression of a PTX-insen-
sitive form of Gi (Figures 1F and 1G) (Digby et al., 2008), but not
by overexpression of the Gs subunit (Figure 1G). Activation of
GPCRs is known to dissociate the Gbg complex from the trimeric
Gi-Gbg complex (Koch et al., 1993). Thus, we further tested the
role of Gi by asking whether disturbing the Gbg dissociation
affects the fast mode. Overexpression of the C terminus of
phosducin or b-ARK, which has been reported to inhibit Gbg
dissociation (Blu¨ml et al., 1997; Koch et al., 1993), almost
completely inhibited the fast mode (Figures 1H and 1I) without
affecting the Ca2+ responses (Figures S2C and S2D). Further-
more, well-known agonists of Gi-coupled GPCR could induce
fast glutamate release; baclofen, GABAB agonist, 2-chloro-
N(6)-cyclopentyladenosine (CCPA), adenosine receptor A1
agonist, arachidonyl-20-chloroethylamide (ACEA), and cannabi-
noid receptor CB1 agonist all activated a fast mode of glutamate
release, which was similar to that induced by TFLLR, without
a measurable Ca2+ increase or a slowmode of glutamate release
(Figures 1J, 1K, S2G, and S2H).
To examine the involvement of Gq signaling, we overex-
pressed RGS-2, which is reported to selectively inhibit the
Gq subunit (Heximer et al., 1997). We found that RGS-2 over-
expression selectively and significantly inhibited both the
slow mode of glutamate release and the associated Ca2+
increase while not affecting the fast mode (Figures 1L, 1M,
S2E, and S2F). Gq signaling activates phospholipase Cb,
producing IP3 and releasing Ca
2+ through the IP3R channel
(Clapham, 2007). Thus, we tested the sensitivity of slow mode
to the Ca2+ chelator, BAPTA. We found that 30 min treatment
with BAPTA-AM eliminated the TFLLR-induced Ca2+ response
and significantly reduced the slow mode, but not the fast
mode (Figures 1N and 1O). These results indicate that the slow
mode is preferentially linked to Gq signaling and subsequent
Ca2+ release. To test the involvement of Gs, which produces
cyclic AMP (cAMP), we applied TFLLR in the presence of
IBMX, an inhibitor of cAMP phosphodiesterase, or forskolin, an
activator of adenylyl cyclase, and found no evidence for the
involvement of cAMP in the fast or slow components of
glutamate release (Figures S2I–S2K).
Vesicular Exocytosis Is Not Involved
Next, we examined whether vesicular exocytosis is involved in
the fast and slow modes of glutamate release. First, we applied
hyperosmotic solution, which causes exocytotic release of
glutamate in neurons (Bekkers and Stevens, 1995), and found
that this evoked no glutamate release from astrocytes (Figures
S3A and S3C; Lee et al., 2007). Unlike neurons, astrocytes
apparently do not possess glutamate-containing vesicles sensi-
tive to hyperosmotic solution. Rose Bengal, which inhibited
glutamate released by mechanical stimulation (Montana et al.,
2004), did not have any effect on the fast or slow modes of28 Cell 151, 25–40, September 28, 2012 ª2012 Elsevier Inc.glutamate released by TFLLR (Figures S3B and S3C).
Treatment of astrocytes with Bafilomycin A1 and Concanamycin
A, which should deplete glutamate from synaptic vesicles,
appeared to block both fast and slow modes, presumably due
to the fact that these compounds almost completely eliminated
the surface expression of GluR1-L497Y in the sensor cell
(Figures S3D–S3G, S3I, and S3K). Tetanus toxin (TeTX) also
caused the similar effect of removing surface GluR1-L497Y
(Figures S3J and S3K), complicating the interpretation of
any results obtained using this toxin. To avoid the effects of
drugs and toxins on the sensor cell, we injected Botulinum toxin
B (BoToxB), together with Ca2+ indicator dye Fura-2, into
individual astrocytes through the patch pipette. This did not
cause any significant effect on the surface expression of
GluR1-L497Y on the sensor cell (Figures S3M and S3P). We
found that BoToxB injection did not have any effect on TFLLR-
induced fast and slow modes (Figures 2A and 2C), although it
completely eliminated glutamate release in the same astrocyte
in response to mechanical stimulation (Figures 2A and 2D), as
previously reported (Araque et al., 2000). In contrast, TeTX
injection substantially decreased the surface expression of
GluR1-L497Y in the sensor cell within 20 min (Figures S3L and
S3P) and TFLLR-induced glutamate release (Figures S3L and
S3O), suggesting that TeTX can readily cross the astrocytic
membrane and affect the surface expression of GluR1-L497Y
in the neighboring sensor cell. As a control experiment, we
injected bovine serum albumin (BSA), instead of BotoxB, and
found that BSA did not have any effect on TFLLR-induced fast
and slow modes of glutamate release (Figures 2B, 2C, S3N,
and S3O) or on mechanical stimulation-induced glutamate
release, as expected (Figures 2B and 2D). From these results,
we conclude that, whereas the glutamate released by mechan-
ical stimulation is sensitive to inhibitors of exocytosis, glutamate
released by TFLLR is not.
Molecular Identities of Fast and Slow Modes
of Glutamate Release
We next examined the possibility that TFLLR induces glutamate
release from astrocytes via channels or transporters. We
screened blockers of various channels and glutamate trans-
porters and found that both the fast and slow modes of release
were blocked by blockers of Ca2+-activated anion channel
(CAAC), such as NPPB, niflumic acid, DIDS (Figures 2E, S4A,
and S4B), and quinine, which blocks two-pore potassium (K2P)
channels (Figures 2F and S4C). Although these blockers are
notorious for their nonspecific effects (Greenwood and Leblanc,
2007; Wang et al., 1997), they did not have any effect on the
sensor, GluR1-L497Y (Figures S4D and S4E). Blockers that did
not show any significant effect include TTX (voltage-gated
sodium channels), Cd2+ (voltage-gated Ca2+ channels), TEA,
Ba2+, Cs+ (potassium channel), CBX (gap junction hemichannel),
and DCPIB (volume-sensitive anion channel) (Figure S4G).
PPADS (P2X channel) appeared to block the fast mode (Fig-
ure S4G), but this was not interpretable because PPADS had
nonspecific effects (Figures S4E and S4H–J). From the results
of this screening, CAAC and K2P channels emerged as strong
candidates as molecular mediators of receptor-mediated gluta-
mate release from astrocytes.
Figure 2. Molecular Identities of Fast and
Slow Glutamate Release
(A) Traces for BoToxB-injected astrocyte (8 mg/ml,
20 min) stimulated with TFLLR (left) and mechan-
ical stimulation (right). Diamond, TFLLR appli-
cation (100 ms, 500 mM). Hexagon, mechanical
stimulation.
(B) Traces for BSA-injected astrocyte (8 mg/ml,
20 min).
(C) Summary graph for BotoxB and BSA injection.
(D) Summary graph for mechanical stimulation
(*p = 0.001).
(E) Traces for glutamate release before (left) and
during 50 mM NPPB (right).
(F) Summary graph for percentage of block by
DIDS (50 mM for 10min), DCPIB (50 mM for 10min),
and quinine (100 mM for 10 min).
(G–J) Traces for each astrocyte overexpressing
control scrambled shRNA (G), Best1-shRNA (H),
TREK-1-shRNA (I), and both Best1- and TREK-1-
shRNAs (J).
(K) Summary graph for astrocytes overexpressing
Best1-shRNA and coexpressing Best1-shRNA-
insensitive, wild-type, and W93C pore mutant
form of Best1 cDNA (**1, p = 0.008; **2, p = 0.009;
n.s., nonsignificance).
(L) Summary graph for astrocytes overexpressing
TREK-1-shRNA and coexpressing rat TREK-1
cDNA, wild-type, and G144E, insensitive for
TREK-1-shRNA (***p = 0.0004; *1, p = 0.047; *2,
p = 0.012; *3, p = 0.048).
All values are mean ±SEM. See also Figures S3,
S4, and S7.To determine the molecular identity of the slow mode, we first
tested the Bestrophin-1(Best1) channel because this Ca2+-
activated anion channel is highly expressed in hippocampal
astrocytes (Park et al., 2009). It also shows unique properties
such as permeability to glutamate (Park et al., 2009) and GABACell 151, 25–40, S(Lee et al., 2010). Although Best1 channel
is permeable to both glutamate and
GABA, it is not likely to mediate GABA
release from hippocampal astrocytes
because hippocampal astrocytes do not
contain GABA (Yoon et al., 2011), unlike
the cerebellar Bergmann glial cells (Lee
et al., 2010). Silencing the Best1 gene
via specific small hairpin RNA (shRNA)
for mouse Best1 selectively reduced the
slow mode without significantly affecting
the fast mode (Figures 2G, 2H, and 2K).
This effect was specific because it was
not observed with a control scrambled
shRNA and was fully rescued by the
cotransfection of Best1-shRNA, along
with an shRNA-insensitive form of Best1
(Figure 2K). However, the addition of a
pore mutation at position 93, from trypto-
phan to cysteine (Best1-W93C) (Zhang
et al., 2010), failed to rescue the slowmode, indicating that permeation of glutamate through the pore
of Best1channel is responsible for the slow mode (Figure 2K).
For the fast mode, we next explored the possibility of TREK-1,
which is a recently proposed K2P channel in astrocytes
(Zhou et al., 2009). An shRNA specific for mouse TREK-1 waseptember 28, 2012 ª2012 Elsevier Inc. 29
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developed (Figures S4K–M) and tested for effects on glutamate
release. Gene silencing of TREK-1 selectively eliminated the fast
mode without affecting the slow mode (Figures 2I and 2L) and
was fully rescued by rat TREK-1, which is insensitive to mouse
TREK-1-shRNA (Figure 2L). However, the addition of a pore
mutation at position 144, from glycine to glutamate (rTREK-1-
G144E) (Brenner and O’Shaughnessy, 2008), failed to rescue
the fast mode. Finally, cotransfecting the shRNAs for Best1
and TREK-1 eliminated both the fast and slow modes (Figures
2J and 2L).
Opening of Glutamate-Permeable Channel by Direct
Binding of Gbg to TREK-1
How can TREK-1, a potassium channel, conduct and release
glutamate? TREK-1-mediated glutamate release is relatively
fast and requires Gi-Gbg dissociation. To answer the question,
we considered a possibility that Gbg directly binds to TREK-1
to open a glutamate-permeable channel. A previous yeast two-
hybrid screen suggested that N terminus of TREK-1 interacts
with GNG4 (subtype 4 of Gg subunit) (Kim et al., 2010). Therefore,
we performed a detailed analysis of N-terminal region of TREK-1
by yeast two-hybrid assay (Figures 3A and S5A). Of the four
segments of N-terminal region of TREK-1, each with 11 or 12
amino acid residues, we found that the N1, N2, and N4 segments
strongly interacted with GNG4, whereas N3 did not (Figures 3A,
3B, and S5B). The interaction of TREK-1 N terminus with GNG4
was also confirmed by MBP pull-down assay (Figure S5C). We
confirmed the interaction between full-length TREK-1 and
GNG4 via coimmunoprecipitation by using the antibodies
against hemagglutinin (HA) and green fluorescent protein (GFP)
after heterologously expressing GFP-GNG4 and HA-TREK-1
in HEK293T cells (Figure 3C). As a positive and negative
control, we performed similar experiments with a well-known
Gbg-interacting channel, GIRK (G-protein-coupled inwardly
rectifying potassium channel), and a noninteracting IRK (inwardly
rectifying potassium channel). We found that GIRK strongly
interacted with GNG4, whereas IRK did not (Figure 3C), as
expected (Huang et al., 1995). Furthermore, RT-PCR analysis
showed that cultured astrocytes express GNG4 (Figure S5G).Figure 3. Direct Interaction between Gbg and TREK-1 Induces Anion C
(A) A schematic illustration represents various domains and amino acid (aa) seque
The N terminus (1–46 aa) is divided into four segments, N1–4. Red pluses, degre
(B) Interaction between subdomains (N1–4) of TREK-1 and GNG4 by the presen
(C) Co-IP assays showing that TREK-1, as well as GIRK1, interacts with GNG4,
(D) GNG4 domain (top). Co-IP assays showing that C terminus of GNG4 interact
(E) I-V curves for Gbg-induced conductance with chloride (black) or glutamate (red
schematic diagram for experiment (in mM, 150 [Cl]in, 150 [Glu]in, 6.09 nM Gbg: 15
(F) Summary graph for four conditions with different internal solutions (*p = 0.019
(G) Summary graph for reversal potential (**p = 0.001).
(H) I-V curves show that glutamate permeability depends on TREK-1. Inset, 150m
shRNA (blue). Coexpression of rat TREK-1 and TREK-1 shRNA (red). G144E of r
(I) Summary bar graph for current amplitude at 100mV (**p = 0.008; *1, p = 0.0
(J) Concentration-response relationship for Gbg on the conductance under chlor
(K) I-V curves show that chloride conductance depends on the competitive peptide
6.09 nM Gbg: 150 mM [Cl
]out.
(L and M) Traces for Gbg-induced current upon membrane rupture (black arrow)
measured (50 s).
(N) Summary bar graph.
All values are mean ±SEM. (*1, p = 0.015; **p = 0.002; *2, p = 0.026.) See also FTo map out the region of GNG4 that interacts with TREK-1, we
divided the GNG4 protein sequence (75 amino acids) into two
segments, N (1–31)- and C (32–75)-terminal segments, and
checked for protein-protein interaction with full-length TREK-1
by coimmunoprecipitation (Figure 3D). The results showed that
C terminus of GNG4 showed strong interaction with TREK-1,
whereas N terminus did not (Figure 3D). To test the specificity
of different GNG isoforms, we first cloned 11 out of 12 known
isoforms of GNG family from the complementary DNAs (cDNAs)
of primary cultured mouse astrocytes. The analysis of sequence
homology between isoforms indicated that there are well-
conserved N-helix and C-helix (Figure S5H), and the phylogenic
tree indicated a close homology betweenGNG1 andGNG11 and
between GNG5 and GNG10 (Figure S5I and Table S1). Then we
performed a coimmunoprecipitation experiment for each GNG
isoform against TREK-1 and found that most GNG isoforms
coimmunoprecipitated with TREK-1 protein. In contrast, GNG5
and GNG10 showed a lack of interaction, and GNG1 and
GNG11 showed a weak interaction (Figure S5J), indicating that
GNG binding to TREK1 is isoform specific.
We then asked whether Gbg can directly open any channels in
cultured astrocytes. We performed whole-cell current recording
with purified Gbg in the patch pipette and found that a large
inward current was induced by intracellularly applied Gbg upon
the membrane rupture (Vh = 70mV). Surprisingly, the reversal
potential of this current (3.8 ± 0.2mV, n = 19) was far away
from the equilibrium potential for K+ (70mV) or Na+ (40mV)
but was near the Cl equilibrium potential (0mV; Figures S5D–
S5F). Ion substitution experiments showed that the Gbg-induced
current was mostly carried by Cl ion because of the linear
current-voltage (I-V) relationship and reversal potential near
0mV, which was observed when identical Cl concentrations
were present on both sides of the plasma membrane (Figure 3E,
black trace). As a control, we used BSA, which did not induce
any significant current (Figure 3E, blue trace). To determine
whether the conductance shows permeability to glutamate,
we substituted Cl in the intracellular pipette solution with gluta-
mate and found that Gbg induced a significant inward current
at 100mV with reversal potential around 40mV (Figure 3E,onductance in Astrocyte
nce of TREK-1. M1-4, four transmembrane domains. P1 and P2, pore domains.
e of interaction between indicated region of TREK-1 and GNG4 from Y2H.
ce of yeast colony in TLH (tryptophan, leucine, and histidine).
but not with IRK1.
s with TREK-1, but not N terminus (bottom).
) and BSA-induced conductance with chloride (blue) or glutamate (green). Inset,
0 [Cl]out).
; ***p = 0.0004).
M [Glu]in, 6.09 nMGbg: 150mM [Cl
]out. Gbg-induced conductancewith TREK-1
at TREK-1 and TREK-1 shRNA (green).
38; *2, p = 0.045).
ide condition (mM, 150 [Cl]in: 150 [Cl
]out).
. Gbg-induced conductance (black) with N1 peptide (red). Inset, 150mM [Cl
]in,
(L) and with 100 mM N1 peptide (M). Red arrows, point of current amplitude is
igure S5.
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Figure 4. Direct Binding of Gbg Protein to TREK-1 Causes Release of Glutamate
(A) A schematic diagram for two-cell sniffer patch. Green cell, HEK293T cell expressing GluR1-L497Y. Blue cell, astrocyte. Blue lines, glass pipette containing
5 mM glutamate and 6.09 nMGbg. Green lines, glass pipette for patching sensor cell. First blue trace, change of holding voltage (Vh) on astrocyte from70mV to
70mV. Current traces both from astrocyte (middle blue) and sensor cell (green). Arrow, point of membrane rupture. Upon voltage step Vh = +70mV in astrocyte
(middle blue), the current amplitude of sensor current (green) decreased. Dotted line, baseline current level. Arrows, measurement of sensor currents.
(B) Summary bar graph for indicated conditions (*p = 0.032, paired t test).
(C) Summary bar graph for percentage of current reduction in response to voltage step.
(D) Two-cell sniffer-patch assay. Blue trace, astrocyte expressing control scrambled shRNA. Green trace, sensor cell. Arrow, time of membrane rupture
on astrocyte.
(E) TREK-1-shRNA-expressing astrocyte and sensor current.
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red trace), indicating a significant glutamate permeability. From
the average shift in reversal potential of 30.9mV produced
by the substitution of intracellular Cl with glutamate (Fig-
ure 3G), we calculated the permeability ratio of glutamate to
Cl (Pglutamate/PCl
) to be 0.27 by using the Goldman-Hodgkin-
Katz equation. In the absence of Gbg, the conductance for
glutamate, as well as that for Cl, was negligible (Figure 3F).
From the concentration-response relationship, EC50 for Gbg
was determined to be 32.4 ng/ml (0.79 nM) (Figure 3J).
To test whether the Gbg-induced glutamate conductance is
mediated by TREK-1, we performed a similar experiment after
silencing the TREK-1 gene with shRNA. Compared to the scram-
bled shRNA (Figure 3H black trace and 3I), we found that mouse
TREK-1-shRNA eliminated the Gbg-induced conductance (blue
trace), which was significantly rescued by coexpression of rat
TREK-1 (red trace). The pore mutant rTREK-1-G144E failed to
rescue the Gbg-induced conductance (green trace). These
results indicate that TREK-1 mediates the glutamate conduc-
tance induced by Gbg. Because N1, N2, and N4 of TREK-1
interact with GNG4, we tested for functional interaction by using
these competitive peptides. Inclusion of competitive peptides
N1, N2, and N4 in the patch pipette significantly reduced Gbg-
induced chloride currents (Figures 3K–3N).
To determine whether activation of TREK-1 by Gbg can release
glutamate from astrocytes, we performed two-cell sniffer patch
(Lee et al., 2010). Under this configuration, two patch pipettes
were used: one containing both Gbg and 5 mM glutamate
to record from an astrocyte and the other for a sensor cell
expressing GluR1-L497Y to detect released glutamate. Upon
membrane rupture, the astrocyte showed a large inward current
(Vh =70mV), and the sensor cell displayed a substantial parallel
current representing glutamate released from the neighboring
astrocyte (Figures 4A and 4B). Outflow of glutamate from
astrocyte was dependent on the electrochemical gradient
because changing the holding potential from 70mV to +70mV
reduced glutamate release by 75% (Figures 4A–4C), as pre-
dicted by the Nernst equation. This glutamate release was
eliminated by silencing the TREK-1 gene in astrocytes and was
rescued by coexpression of rat TREK-1 (Figures 4D–4F). The
pore mutant rTREK-1-G144E failed to rescue (Figure 4F). These
results indicate that astrocytic glutamate release can be directly
induced by Gbg and that TREK-1 mediates this release by direct
permeation of glutamate through its pore. Finally, we tested
whether TREK-1-mediated glutamate release requires direct
binding of Gbg to TREK-1 by utilizing the N-terminal segments
of TREK-1 to compete for binding of Gbg to TREK-1. We per-
formed two-cell sniffer patch and found that N1 peptide signifi-
cantly reduced the Gbg-induced glutamate release, as well as
Gbg-induced current (Figures 4H and 4I), whereas N3 had no
significant effect compared to the control condition without
any peptide (Figures 4G and 4I).(F) Summary bar graph for sensor current (green) (**p = 0.008; *1, p = 0.041; *2,
(G) Current traces for astrocyte injected with Gbg and N3 peptide (blue) and sens
(H) Current trace for astrocyte injected with Gbg and N1 peptide (blue) a
measurement point.
(I) Summary bar graph for percentage of full activation (**1, p = 0.005; **2, p = 0.
All values are expressed as mean ±SEM.Best1 Is a Glutamate-Permeable Channel
We recently demonstrated that Best1 channel is activated by
intracellular Ca2+ (EC50 = 150 nM) with considerable permeability
to GABA (Lee et al., 2010; Park et al., 2009) and that hippo-
campal astrocytes express CAAC with glutamate permeability
(Lee et al., 2010; Park et al., 2009). To test whether heterolo-
gously expressed Best1 is also permeable to glutamate, we
measured Best1-mediated anion conductance in HEK293T cells
expressing mouse Best1 gene by using patch pipette solution
with high Ca2+ (4.5 mM free Ca2+) for maximal channel activation
and Cl or glutamate as the solely permeant anion (145 mM Cl
or glutamate). The I-V relationship of currents flowing through
Best1 was determined as illustrated in Figure 5A (black trace).
We found a significant Ca2+-induced conductance carried by
the efflux of Cl or glutamate at 70mV, which was eliminated
by the absence of free Ca2+ in the pipette solution (Figures 5A
and 5B). The estimated permeability ratio of glutamate and
Cl was Pglutamate/PCl = 0.67 (Erev of internal Cl
: 1.9 ± 0.8mV,
n = 9; Erev of internal glutamate: 6.4 ± 2.0mV, n = 11;
p = 0.0019) according to the Goldman-Hodgkin-Kats equation.
These results indicate that Best1 channels show substantial
permeability to glutamate, which is consistent with the previous
reports (Lee et al., 2010; O’Driscoll et al., 2009; Park et al., 2009).
To determine whether such glutamate efflux through Best1
channel can be detected by a neighboring cell, we performed
the two-cell sniffer patch between source cell and sensor cell
(Figure 5C; Lee et al., 2010). The internal solution for cells
expressing Best1 channel contained Cl or glutamate for anion,
and upon rupture of membrane, Best1 was activated by high
Ca2+ in the pipette solution (4.5 mM free Ca2+; Figure 5C). We
found that Best1 displayed a significant glutamate conductance
(Figure 5E, top blue trace) and that this current was associated
with a sensor current (Figure 5E, bottom green trace). We
found that the release of glutamate depended on permeation
through Ca2+-activated Best1 (Figure 5D) because it was
absent (1) when Best1 was not expressed, (2) when glutamate
was replaced by Cl, (3) when Ca2+ was absent (Figure 5F),
and (4) when the source cell expressed the pore mutant of
Best1 (W93C).
Differential Localization and Neuronal Targets
of TREK-1 and Best1
To see whether the same kind of glutamate release is observed
ex vivo, we performed sniffer-patch experiment and recorded
CNQX-sensitive glutamate release from a single, acutely iso-
lated, GFP-positive hippocampal astrocyte, which was prepared
from the brain slices of adult GFAP-GFP transgenic mice (Fig-
ure 6A). We similarly observed fast and slowmodes of glutamate
release (Figures 6B and 6C) with similar kinetic properties (fast
mode latency: 61.5 ± 5.4 ms, n = 15; slow mode peak: 22.5 ±
4.3 s, n = 16). To test whether the same molecules are involvedp = 0.038).
or current (green).
nd sensor current (green). Black arrow, membrane rupture. Red arrow,
001; n.s., nonsignificance).
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Figure 5. Best1ReleasesGlutamate byCa2+
(A) I-V for HEK293T cells expressingmouse Best1.
Pipette solution containing 4.5 mM Ca2+ + 145mM
Cl (Cs-Cl, black trace), 4.5 mM of Ca2+ + 145 mM
of glutamate (Cs-glutamate, red trace), or 0 mM
Ca2+ + 145 mM glutamate (Cs-glutamate [0 Ca2+],
green trace). Untransfected HEK293T cells using
pipette solution containing 4.5 mM of Ca2+ +
145 mM Cl (untransfected, blue trace).
(B) Summary bar graph for averaged current
amplitude at 70mV (*p = 0.03) for each group.
Number of cells from at least two independent
culture batches is indicated on each bar.
(C) Two-cell sniffer patch using Best1- (source
cell) and GluR1L497Y-expressing (sensor cell)
HEK293T cells.
(D) Summary bar graph representing averaged
responses in sensor cell. The source cells such as
wild-type Best1-expressing cells, untransfected
cells or Best1W93C (pore mutant)-expressing
cells with 4.5 mM Ca2+ + 145 mM glutamate-con-
taining pipette solution, Best1-expressing cells
with 0 mM Ca2+ + 145 mM glutamate-containing
pipette solution, and Best1-expressing cells with
4.5 mMCa2+ + 145mMchloride-containing pipette
solution (**1, p = 0.005; ***p = 0.004; **2, p = 0.005;
*p = 0.011).
(E and F) Traces for two-cell sniffer patch from
Best1-expressing source cell (Best1, blue) and
sensor cell (green). Best1-expressing cells were
patched and ruptured by using 145 mM gluta-
mate-containing pipette solution with high 4.5 mM
Ca2+ (E) or 0 mM Ca2+ (F). Arrowheads, time point
of membrane rupture of source cell.
All average values are expressed as mean ±SEM.in vivo, we first generated a lentivirus carrying TREK-1 shRNA
and injected into wild-type hippocampal CA1 to perform
sniffer-patch experiment from acutely isolated astrocytes. We
found that TREK-1 shRNA selectively eliminated fast mode, as
compared to the scrambled shRNA (Figures 6D and 6G). Then
we tested Best1 knockout mice (Figures S7A and S7B; Marmor-
stein et al., 2006) and found that slow mode was selectively
eliminated, as compared to the astrocytes of wild-type mice
(Figures 6E and 6G). Finally, TREK-1 shRNA in Best1 knockout
mice eliminated both fast and slow modes (Figures 6F and 6G).
Astrocytes show elaborate structures in vivo with several
key cellular compartments. Of these structures, microdomains34 Cell 151, 25–40, September 28, 2012 ª2012 Elsevier Inc.tightly wrap around each synapse
(Grosche et al., 1999; Halassa et al.,
2007). To determine the subcellular distri-
bution of the Best1 and TREK-1 channels
and thus to predict the in vivo function,
we performed electron microscopic
immunohistochemistry with antisera
against Best1 or TREK-1 and against
GFP in GFAP-GFP mice. We found
that Best1 channels were preferentially
expressed at the surface membrane of
microdomains adjacent to glutamatergic
synapses (Figure 6H), as compared toother cellular compartments such as cell body and large
processes (Figures 6J and S6A–S6C). The labeling in the large
processes was located inside the processes rather than near
or at the plasma membrane (Figure S6B), suggesting that these
proteins are being transported out to the distal microdomains. In
contrast to Best1, TREK-1 antibody showed opposite distribu-
tion pattern—namely, at the surface of cell body and processes,
but not at the microdomains (Figures 6I, 6J, and S6D–S6F).
Next, the total amount of glutamate release from a single
astrocyte was estimated based on the experimental values of
sniffer-patch recording by using a diffusion model to fit the
experimental measurements. The model was optimized to
consider the geometrical constraints of sniffer patch and to
capture the diffused-away glutamate molecules that the sensor
failed to detect (Figure 7A, see Extended Experimental Proce-
dures). We calculated that one typical astrocyte releases
0.34 fmol of glutamate during the fast mode and 1.35 fmol during
the slow mode (Figures 7B and 7C). These values could be
compared to 2.64 fmol for the mechanical stimulation-induced
glutamate release at the peak of response (Figures 7B and 7D).
These estimations are comparable to the previously reported
estimations (0.078–0.2 fmol by glutamate imaging [Domercq
et al., 2006] and 3 fmol by HPLC [Takano et al., 2005]).
Using the same diffusion model, we simulated glutamate
release from the point sources uniformly distributed on the astro-
cytic membrane and predicted the concentration of glutamate
from 10 to 40 nm away from the neuronal membrane to mimic
the astrocyte-neuron interaction (Figures 7H and 7I). Because
the cytosolic glutamate concentration in astrocytes is as high
as 2–10 mM (Ye et al., 2003), glutamate is assumed to flow
out, down the gradient when TREK-1 and Best1 channels
open. The simulated glutamate concentration for the fast mode
release via TREK-1 was 100 mM (Figure 7E) at the target
receptor of the apposing neuronal membrane, whereas for
slowmode via Best1, the concentrationwas0.9 mM (Figure 7F).
From these values, we can predict that the slow mode will pref-
erentially activate neuronal NMDA receptors (NMDAR), whereas
the fast mode will preferentially activate mGluR in addition to
NMDAR, according to the reported concentration-response
relationship for each glutamate receptor (Figure 7G).
Finally, we tested these predictions by performing slice patch
clamp recordings from CA1 pyramidal neurons to detect PAR1-
induced astrocytic glutamate release (Figure 7J). The released
glutamate is detected as an NMDAR-mediated current in the
presence of nominal external Mg2+ (5 mM). We found that TFLLR
induced a small but significant NMDAR-mediated current
(Figure 7K), which was almost completely eliminated in the
Best1 knockout mice (Figure 7L). TREK-1-shRNA injected into
Best1 knockout mice further reduced the small portion of re-
maining NMDAR-mediated current (Figure 7M). To test whether
astrocytic or neuronal Best1 is mediating the glutamate release,
we employed the cell-type-specific gene-silencing system that
combines the GFAP-CreERT2 mice (astrocytic Cre) or CaMKII-
Cre mice (neuronal Cre) with Cre-lox-regulated shRNA cassette
(Lee et al., 2010; Ventura et al., 2004). We could also achieve
temporal control of Cre expression in GFAP-CreERT2 mice by
intraperitoneal injection of tamoxifen. Using this system, we
found that Best1-shRNA significantly reduced TFLLR-induced
glutamate release in the absence of tamoxifen (sunflower oil
injection) in GFAP-CreERT2 mice or in CaMKII-Cre mice (Fig-
ure 7N), as compared to the scrambled shRNA control (Fig-
ure 7O). On the other hand, tamoxifen injection significantly
rescued the TFLLR-induced NMDAR current in GFAP-CreERT2
mice (Figure 7O), indicating that astrocytic Best1 is responsible
for the majority of TFLLR-induced glutamate release. To see
whether TFLLR-induced current is a genuine NMDAR-mediated
current, we performed similar recordings in the presence of
2 mM external Mg2+ and obtained instant I-V relationship upon
voltage ramp ranging from 100mV to +20mV. The I-V relation-
ship of TFLLR-induced current showed a typical V-shape thatis a hallmark of Mg2+-dependent NMDAR-mediated conduc-
tance (Figures 7P and 7R). This V-shaped I-V was eliminated
by the treatment with APV, a blocker of NMDAR (Figures 7Q
and 7R). Taken together, these results indicate that Best1-
mediated astrocytic glutamate release targets neuronal postsyn-
aptic NMDAR, whereas TREK-1-mediated release does not.
DISCUSSION
Our study answers the ongoing controversies about the astro-
cytic glutamate release mechanisms. Now we understand why
many have reported the evidence for vesicular glutamate release
from astrocytes. Many studies in the past used mechanical
stimulation to induce glutamate release (Araque et al., 1998,
2000; Montana et al., 2004). Our study demonstrates the exis-
tence of both BoToxB-sensitive and channel-mediated releases;
strong stimuli, such as mechanical stimulation, cause BoToxB-
sensitive glutamate release, whereas GPCR activation leads to
channel-mediated release. We also note the critical problems
of using inhibitors of vesicular release such as Bafilomycin A1,
Concanamycin A, and Tetanus toxin. These inhibitors actively
remove the surface AMPA receptors, thus impairing the sensor
for glutamate and obscuring the interpretation of the results.
Furthermore, these inhibitors and BoToxB significantly reduced
the surface expression of TREK-1 in heterologous expression
system (Figures S7C and S7D) and Best1 channels in astrocytes
(Figures S7E and S7F). Therefore, these inhibitors should be
used with caution, and the past results should be reinterpreted.
Our electron microscopy results indicate that Best1 is prefer-
entially located at the microdomains near synapses, whereas
TREK-1 is preferentially located at the soma and processes,
providing differential sources for fast glutamate release by
TREK-1 away from the synapse and slow glutamate release by
Best1 near the synapse. In the recent report by Agulhon et al.
(2010), the authors used MrgA1 transgenic mice with astrocytic
expression of exogenous MrgA1 receptor and showed a lack
of effect upon activation of this receptor. The authors concluded
that astrocytic Ca2+ had no effect on synaptic transmission and
plasticity (Agulhon et al., 2010). This lack of effect could be due
to an inappropriate targeting of the exogenously introduced
MrgA1 receptor (a Gq-coupled GPCR), which should be targeted
near Best1 channels in the distal microdomains for proper
release and function. In contrast to the exogenous MrgA1, we
demonstrate that the activation of endogenous PAR1 releases
Ca2+-dependent astrocytic glutamate via Best1 channel and
subsequently activates neuronal NMDAR.
Furthermore, our study demonstrates that glutamate release
upon receptor activation is mostly due to channel-mediated
release (Figure 6K), which is in line with the recent review by
Hamilton and Attwell (2010) and other previous reports suggest-
ing anion-channel-mediated release but without identifying the
molecular identity of the channel (Li et al., 2012; Takano et al.,
2005). We determined the molecular identity of the fast mode
as TREK-1 and the slow mode as Best1 channel. We previously
reported that tonic GABA release is mediated by Best1 in cere-
bellar astrocytes (Lee et al., 2010). We subsequently reported
that astrocytes of CA1 hippocampus do not contain GABA,
and thus there is very little tonic GABA release detected fromCell 151, 25–40, September 28, 2012 ª2012 Elsevier Inc. 35
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CA1 pyramidal neurons (Yoon et al., 2011). Although Best1 is
permeable to both glutamate and GABA, it should mediate
glutamate release from hippocampal astrocytes because they
do not contain GABA. In addition, our study demonstrates that,
when a Gi-coupled GPCR (GABAB, CB1, or A1R) is activated,
there is a concurrent induction of Ca2+-independent glutamate
release that is linked to Gi activation, dissociation of Gbg, binding
of Gbg to N terminus of TREK-1, and opening of TREK-1 channel.
Finally, we demonstrate the ability of a K2P channel perme-
ating and releasing glutamate upon binding of Gbg. There
have been only few channels that directly interact with Gbg.
These include GIRK (Huang et al., 1995) and alpha subunits of
some voltage-gated Ca2+ channels (Li et al., 2005). The K2P
channel is a new member of the family of channels that show
direct interaction with Gbg. The remarkable ability of a potas-
sium-permeable channel to dilate its pore to permeate large
molecules such as glutamate is quite interesting. Pore dilation
is a rare phenomenon that has been observed with few ion
channels, such as TRPV1 (Binshtok et al., 2007) and P2X7 (Vir-
ginio et al., 1999). A detailed structural analysis should give us
new insights on how pore dilation in TREK-1 can occur upon
the binding of Gbg.
In conclusion, astrocytes display multiple routes of glutamate
release, each with a unique molecular mechanism, specific
timescale, differential location, and different neuronal target
receptor. Such diversity teaches us that astrocytes, once a ne-
glected brain cell type, are emerging as an important source of
glutamate, which can potentially influence neuronal excitability
under various physiological as well as pathological conditions.
EXPERIMENTAL PROCEDURES
Sniffer-Patch Technique
Sniffer patch was composed of Fura-2 imaging for Ca2+ from astrocytes and
current recording from HEK293T cells expressing GluR1-L497Y. To release
glutamate from astrocyte, PAR-1 was activated by pressure application of
TFLLR peptide. On the day of experiment, cultured mouse astrocytes
(HEK293T cells added) were incubated with 5 mM Fura-2 AM (mixed
with 5 ml of 20% Pluronic acid) (Invitrogen) for 40min, washed at room temper-
ature, and subsequently transferred to the microscope stage for imaging.
External solution contained (in mM): 150 NaCl, 10 HEPES, 3 KCl, 2 CaCl2,
2 MgCl2, and 5.5 glucose (pH adjusted to pH 7.3 and osmolarity adjusted toFigure 6. TREK-1 and Best1Mediate Fast and SlowGlutamate Release
in CA1 Hippocampal Astrocytes
(A) DIC, GFP (astrocyte), and ds-Red (sensor cell) images for sniffer patch
GFAP-GFP mouse.
(B) Sensor current traces from one astrocyte before and during 10 mM CNQX.
(C) Summary bar graph.
(D) Traces for TREK-1-shRNA-expressing astrocyte.
(E) Trace for Best1 knockout (KO) mouse.
(F) Trace for Best1 KO mouse expressing TREK-1-shRNA.
(G) Summary bar graph (**1, p = 0.002; **2, p = 0.001; **3, p = 0.002; and ***p =
(H and I) Electron microscopic immunostaining for Best1 (H) and TREK-1 (I) comb
Best1 and TREK-1 are stained with immunogold with silver enhancement (da
amorphous deposits, arrows). Pr, presynapse; Po, postsynapse.
(J) Summary graph for percentage (%) of gold particles for TREK-1 and Best1 lo
p = 0.0005; **p = 0.008; ***2, p = 0.0001).
(K) Molecular model of receptor-mediated glutamate release in astrocyte. Upon
glutamate release, whereas Gaq-mediated signaling and Ca
2+ induce slow mode
All values are expressed as mean ±SEM. See also Figure S6.325 mOsmol kg1). Intensity images of 510 nm wavelength were taken
at 340 nm and 380 nm excitationwavelengths by using iXon EMCCD (ANDOR).
Two resulting images were used for ratio calculations in Imaging Workbench
version 6.2 (Indec Systems). GluR1L497Y-mediated currents were recorded
from HEK293T cells under voltage clamp (Vh = –70mV) using Multiclamp
700B amplifier acquired with pClamp 9.2 (Molecular Devices). Recording
electrodes (4–7MU) were filled with (mM): 110 Cs-Gluconate, 30 CsCl,
0.5 CaCl2, 10 HEPES, 4 Mg-ATP, 0.3 Na3-GTP, and 10 BAPTA (pH adjusted
to 7.3 with CsOH and osmolarity adjusted to 290–310 mOsm/kg with sucrose).
For simultaneous recording, Imaging Workbench was synchronized with
pClamp 9.2.
To study Gi pathway, Pertussis toxin, pCDNA3.1-SS-ECFP-TM-Gi1-CG
(GiCG), and pCDNA3.1-SS-ECFP-TM-Gs were used. To study the dissocia-
tion of Gi-Gbg pathway, pRK-b-Ark-C terminus, pIRES2-dsRED-Phosducin-
C terminus, and specific Gi agonists (Baclofen for GABAB, CCPA for adenosine
receptor 1, and ACEA for Cannabinoid receptor) were used. To study Gq
pathway, BAPTA-AM and pSPORT6-RGS-2 were used. To inhibit vesicular
release, Botulinum toxin was injected with impermeable Fura-2 to a single
astrocyte. To inhibit anion channels, NPPB, NFA, DIDS, and quinine were
used. To test whether glutamate release involved TREK-1, pSicoR-TREK-1-
shRNA to gene-silence TREK-1 expression and pIRES2-GFP-TREK-1(rat) for
the rescue experiment were used. To test whether glutamate release involves
Best1, pSicoR-Best1-shRNA for blocking Best1 expression and pSicoR-
Best1-shRNA and pIRES2-dsRed-Best1 (shRNA-insensitive form) for rescue
experiment were used.
Two-Cell Sniffer Patch
Upon membrane rupture, currents were recorded from astrocyte under
voltage clamp (Vh = –70mV). Recording electrodes (4–7MU) were filled
with (mM): 5 glutamate, 135 CsCl, 0.5 CaCl2, 10 HEPES, 4 Mg-ATP,
0.3 Na3-GTP, 10 BAPTA, and 6.09 nM Gbg (pH adjusted to 7.3 with CsOH
and osmolarity adjusted to 290–310 mOsm/kg with sucrose). In the competi-
tive peptide assay, 100 mM N1-4 synthesized peptides were added to patch
pipette and injected into astrocyte. GluR1L497Y-mediated currents were
recorded from HEK293T cells under voltage clamp (Vh = –70mV). Recording
electrodes (4–7 MU) were filled with (mM): 110 Cs-Gluconate, 30 CsCl,
0.5 CaCl2, 10 HEPES, 4 Mg-ATP, 0.3 Na3-GTP, and 10 BAPTA (pH adjusted
to 7.3 with CsOH and osmolarity adjusted to 290–310 mOsm/kg with sucrose).
Purified bovine Gbg (Calbiochem 371768) was injected into astrocyte, and the
current amplitude was measured 10 min after membrane rupture.
Biochemical Evidence for Interaction of TREK-1 and Gg
The binding partners of N terminus of TREK-1 were screened by yeast
two-hybrid system (Y2H) (Kim et al., 2010). The binding site of TREK-1 on
GNG4 was identified by Y2H and was confirmed by MBP pull-down assay
and coimmunoprecipitation. The binding domain of GNG4 on TREK-1 wasin Acutely Dissociated Astrocytes and ShowDifferential Localization
from acutely dissociated CA1 hippocampal astrocyte prepared from adult
0.0008).
ined with immunostaining for GFP in hippocampal CA1 of GFAP-GFP mouse.
rk specks, arrowheads), and GFP is stained with immunoperoxidase (dark
cated on the plasma membrane of cell body, process, and microdomain (***1,
PAR-1 activation, dissociated Gbg activates TREK-1 to induce fast mode of
of Best1-mediated glutamate release.
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Figure 7. Diffusion Modeling Predicts the Concentrations of Fast and Slow Modes and Their Target Neuronal Receptors: Confirmation
by Slice Whole-Cell Recording
(A) The schematic diagram of the diffusion model simulation. Geometry of a single astrocyte on an impermeable boundary is modeled by a square of
100 mm 3 100 mm.
(B) Based on the normalized electrical responses captured by the sensor (HEK293T cell), the original release of glutamate from the astrocyte was estimated.
According to the reconstructed release, the normalized responses are calculated. The release by TFLLR stimulation is divided into two modes of the leading
transient (fast) followed by the smooth (slow).
(C) According to the simulation result, fast and slow modes release about 0.34 fmol and 1.35 fmol, respectively. Peak of fast mode is higher than that of slow
mode, but slow mode continuously releases glutamate in comparison to fast mode where an instantaneous release occurs.
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determined by coimmunoprecipitation after expressing N or C terminus of
GNG4 in HEK293T cells, together with full-length TREK-1.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at http://dx.doi.
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